Pharmaceutical Technology Europe
December 01, 2009
Talking Point
21
12
When it comes to quality assurance and quality control in pharmaceutical solid dose manufacture, Fourier-Transform Near Infrared spectroscopy may be the answer.
December 01, 2009
Analytics
21
12
The quality assurance environment is forcing pharmaceutical companies to face new challenges. In light of this, the authors conducted a study of professionals from some of the world's top pharmaceutical companies to identify key QA concerns.
December 01, 2009
Analytics
21
12
Manual sample preparation methods for solid dose pharmaceuticals have a number of inherent disadvantages, primarily because they are time consuming and unpredictable.
December 01, 2009
Special Feature
21
12
What have been the key innovations that have shaped current aseptic practices and techniques?
December 01, 2009
21
12
It's the end of the year already and I hope you are looking forward to the festive period and the opportunity to wind down and spend some quality time with family and friends.
December 01, 2009
Spotlight
21
12
Governments, regulators and international agencies continue to defend against counterfeiters; in particular, the European Commission has outlined measures that may help to better regulate pharmaceutical distributors.
December 01, 2009
Ask the Expert
21
12
Why is the correct storage of stem cells so important for the future of medical innovation?
December 01, 2009
Outsourcing Review
21
12
Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
December 01, 2009
Manufacturing
21
12
The application of roll compaction as a dry granulation method for three different drug types — herbal dry extract, poorly compactable drug and a sustained-release matrix tablet &#amp;151; was examined.
December 01, 2009
Special Feature
21
12
Each sector of the pharma industry is fraught with challenges and weighty regulations; aseptic processes and techniques are no exception.
December 01, 2009
Special Feature
21
12
Closed vial technology has been designed to address the challenges - potential contamination, counterfeiting and process complexity - associated with the aseptic filling of injectable drugs.